SAMAH RAMADAN-NASSAR: Open Payments
NPI 1134521636 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 9 payments from 5 companies in 2025. Trend: 2023 $250 · 2024 $141 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $216 |
| Novo Nordisk Inc | 3 | $159 |
| ABBVIE INC. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $113 |
| PFIZER INC. | 2 | $28 |
Products named: REZDIFFRA, Wegovy, SKYRIZI, TREMFYA, VELSIPITY, XELJANZ.
Industry payments across WI — which companies pay providers there.
